Olymvax Biopharmaceuticals Inc

Company Description

Founded in 2009, Olymvax Biopharmaceuticals Inc. is a High-techenterprise, focusing on the R&D, production and marketing ofhuman-use vaccine. Itsregistered capital is 205.68million CNY.The factory covers an area of 5.4acres, with77,000 m2 (828,800square feet) in the construction plan and 39,000m2 alreadyfinished. Up to the end of December, 2016, the company had 188staffs, among which, 25 have master's degree or above, accountingfor 13.30% of the associates; 97 have abachelor's degreeor above, in 51.5% of the total.